ArticleJournal of biochemical and molecular toxicology2025
Functional and Transcriptional Disruption of Hepatic ABC Transporters by Environmentally Relevant Short-Chain Per- and Polyfluoroalkyl Substances (PFAS).
Article in Journal of biochemical and molecular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice.Toxics · 2026Review
- Functional and Transcriptional Disruption of Hepatic ABC Transporters by Environmentally Relevant Short-Chain Per- and Polyfluoroalkyl Substances (PFAS).Journal of biochemical and molecular toxicology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) represent a large class of > 11,000 synthetic organofluorine compounds that are globally distributed and consistently detected in human serum. Recent studies suggest that environmentally relevant exposures to short-chain PFAS can disrupt ATP-binding cassette (ABC) transporters, which regulate xenobiotic disposition and are critical for human health. This study examined the effects of short-term (45 min) and long-term (48 h) exposures to 1 nM or 1 µM of four short-chain PFAS, perfluorobutanesulfonic acid (PFBS), perfluorohexanoic acid (PFHxA), perfluorohexanesulfonic acid (PFHxS), and 6:2 fluorotelomer alcohol (6:2 FTOH), using differentiated HepaRG hepatocytes. Functional assays evaluated changes in efflux activity, while gene expression analysis quantified transcriptional responses across 38 ABC transporters. Following 48-h exposures, both 1 nM and 1 µM treatments significantly decreased the retention of fluorescent substrates CMFDA, BODIPY-cholesterol, Hoechst 33342, and Rhodamine 123 relative to controls, indicating enhanced efflux transporter activity. Consistent with these results, transcriptional analysis revealed significant upregulation of multiple ABC genes, including ABCG2 (BCRP), ABCB1 (P-gp/MDR1), and ABCC1 (MRP1). In contrast, short-term exposures produced no measurable effects on efflux activity. Together, these findings demonstrate that environmentally relevant concentrations of short-chain PFAS can alter the expression and activity of key hepatic ABC transporters. Such changes may disrupt the handling of endogenous compounds and pharmaceuticals, raising concerns that low-level PFAS exposure could influence drug disposition and human health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.